

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cilium or flagellum-dependent cell motility (GO:0001539) | 9.57733736 |
| 2 | cilium movement (GO:0003341) | 8.98613054 |
| 3 | motile cilium assembly (GO:0044458) | 8.60695478 |
| 4 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 8.44616560 |
| 5 | epithelial cilium movement (GO:0003351) | 8.25954967 |
| 6 | axoneme assembly (GO:0035082) | 6.20331926 |
| 7 | regulation of cilium movement (GO:0003352) | 5.13370626 |
| 8 | mitotic sister chromatid cohesion (GO:0007064) | 4.97941328 |
| 9 | left/right pattern formation (GO:0060972) | 4.85483208 |
| 10 | intraciliary transport (GO:0042073) | 4.65563731 |
| 11 | centriole assembly (GO:0098534) | 4.63036048 |
| 12 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.47303051 |
| 13 | ventricular system development (GO:0021591) | 4.27981716 |
| 14 | protein localization to cilium (GO:0061512) | 3.95948025 |
| 15 | positive regulation of cell cycle checkpoint (GO:1901978) | 3.91813714 |
| 16 | left/right axis specification (GO:0070986) | 3.89354048 |
| 17 | cilium organization (GO:0044782) | 3.84254872 |
| 18 | primary alcohol catabolic process (GO:0034310) | 3.80653358 |
| 19 | tolerance induction (GO:0002507) | 3.76661481 |
| 20 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.73911659 |
| 21 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.73911659 |
| 22 | centriole replication (GO:0007099) | 3.69213717 |
| 23 | cilium assembly (GO:0042384) | 3.68145085 |
| 24 | diterpenoid biosynthetic process (GO:0016102) | 3.66481778 |
| 25 | regulation of autophagic vacuole assembly (GO:2000785) | 3.64196001 |
| 26 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.60033065 |
| 27 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.44036638 |
| 28 | regulation of DNA endoreduplication (GO:0032875) | 3.41097603 |
| 29 | microtubule bundle formation (GO:0001578) | 3.35756405 |
| 30 | nuclear pore organization (GO:0006999) | 3.33004311 |
| 31 | terpenoid biosynthetic process (GO:0016114) | 3.32093670 |
| 32 | rRNA catabolic process (GO:0016075) | 3.30650536 |
| 33 | pore complex assembly (GO:0046931) | 3.28471965 |
| 34 | Golgi transport vesicle coating (GO:0048200) | 3.27408652 |
| 35 | COPI coating of Golgi vesicle (GO:0048205) | 3.27408652 |
| 36 | DNA unwinding involved in DNA replication (GO:0006268) | 3.24201433 |
| 37 | vitamin transmembrane transport (GO:0035461) | 3.23083809 |
| 38 | establishment of integrated proviral latency (GO:0075713) | 3.23041266 |
| 39 | nuclear pore complex assembly (GO:0051292) | 3.21627083 |
| 40 | sister chromatid segregation (GO:0000819) | 3.20763330 |
| 41 | DNA topological change (GO:0006265) | 3.17817396 |
| 42 | regulation of vacuole organization (GO:0044088) | 3.16453679 |
| 43 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.13756737 |
| 44 | mitotic chromosome condensation (GO:0007076) | 3.11902612 |
| 45 | ATP synthesis coupled proton transport (GO:0015986) | 3.09877046 |
| 46 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.09877046 |
| 47 | regulation of RNA export from nucleus (GO:0046831) | 3.08794214 |
| 48 | positive regulation of interferon-alpha production (GO:0032727) | 3.08083428 |
| 49 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.07191545 |
| 50 | nucleoside diphosphate phosphorylation (GO:0006165) | 3.05818866 |
| 51 | response to xenobiotic stimulus (GO:0009410) | 3.05210442 |
| 52 | establishment of chromosome localization (GO:0051303) | 3.00699671 |
| 53 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.99728630 |
| 54 | metaphase plate congression (GO:0051310) | 2.98995940 |
| 55 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.97003798 |
| 56 | microtubule depolymerization (GO:0007019) | 2.96801279 |
| 57 | cilium morphogenesis (GO:0060271) | 2.95881609 |
| 58 | regulation of microtubule-based movement (GO:0060632) | 2.95647684 |
| 59 | intra-S DNA damage checkpoint (GO:0031573) | 2.94748174 |
| 60 | mitotic metaphase plate congression (GO:0007080) | 2.94604871 |
| 61 | regulation of centriole replication (GO:0046599) | 2.93826863 |
| 62 | regulation of interferon-alpha production (GO:0032647) | 2.93448045 |
| 63 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.92760733 |
| 64 | modulation by symbiont of host immune response (GO:0052553) | 2.91649601 |
| 65 | positive regulation by symbiont of host defense response (GO:0052509) | 2.91649601 |
| 66 | modulation by symbiont of host defense response (GO:0052031) | 2.91649601 |
| 67 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.91649601 |
| 68 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.91649601 |
| 69 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.91649601 |
| 70 | proteasome assembly (GO:0043248) | 2.90041358 |
| 71 | microtubule-based movement (GO:0007018) | 2.88570073 |
| 72 | regulation of interleukin-13 production (GO:0032656) | 2.88561670 |
| 73 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.88517664 |
| 74 | mitotic sister chromatid segregation (GO:0000070) | 2.88450998 |
| 75 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.86264173 |
| 76 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.86264173 |
| 77 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.86264173 |
| 78 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.86233873 |
| 79 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.85990028 |
| 80 | negative regulation of B cell mediated immunity (GO:0002713) | 2.85990028 |
| 81 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.83984490 |
| 82 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.83815161 |
| 83 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.83100341 |
| 84 | ethanol metabolic process (GO:0006067) | 2.83067588 |
| 85 | eosinophil chemotaxis (GO:0048245) | 2.81728951 |
| 86 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.79914683 |
| 87 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.78109814 |
| 88 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.78109814 |
| 89 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.78094237 |
| 90 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.78094237 |
| 91 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.78094237 |
| 92 | regulation of spindle organization (GO:0090224) | 2.77770081 |
| 93 | ribosome assembly (GO:0042255) | 2.77024676 |
| 94 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.76850660 |
| 95 | electron transport chain (GO:0022900) | 2.76536715 |
| 96 | DNA ligation (GO:0006266) | 2.76282529 |
| 97 | histone H2A acetylation (GO:0043968) | 2.75219866 |
| 98 | negative regulation of histone methylation (GO:0031061) | 2.74354325 |
| 99 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.72846096 |
| 100 | respiratory electron transport chain (GO:0022904) | 2.71386405 |
| 101 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.71303548 |
| 102 | negative regulation of ligase activity (GO:0051352) | 2.71303548 |
| 103 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.70782580 |
| 104 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.70782580 |
| 105 | cellular component assembly involved in morphogenesis (GO:0010927) | 2.70350755 |
| 106 | ATP-dependent chromatin remodeling (GO:0043044) | 2.70283817 |
| 107 | regulation of spindle checkpoint (GO:0090231) | 2.68840222 |
| 108 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.68344245 |
| 109 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.68277434 |
| 110 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.68028928 |
| 111 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.67909175 |
| 112 | positive regulation of tolerance induction (GO:0002645) | 2.65305684 |
| 113 | mitotic nuclear envelope disassembly (GO:0007077) | 2.64672048 |
| 114 | regulation of interleukin-5 production (GO:0032674) | 2.64378326 |
| 115 | regulation of centrosome duplication (GO:0010824) | 2.63007360 |
| 116 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.62926146 |
| 117 | regulation of mitotic spindle organization (GO:0060236) | 2.62858940 |
| 118 | positive regulation of ligase activity (GO:0051351) | 2.62001974 |
| 119 | NLS-bearing protein import into nucleus (GO:0006607) | 2.61628630 |
| 120 | spliceosomal snRNP assembly (GO:0000387) | 2.60086199 |
| 121 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.59976303 |
| 122 | mRNA splicing, via spliceosome (GO:0000398) | 2.59976303 |
| 123 | neutrophil activation involved in immune response (GO:0002283) | 2.59943528 |
| 124 | ribosome biogenesis (GO:0042254) | 2.59235551 |
| 125 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.59107815 |
| 126 | protein refolding (GO:0042026) | 2.58398234 |
| 127 | RNA splicing, via transesterification reactions (GO:0000375) | 2.56319273 |
| 128 | regulation of translational termination (GO:0006449) | 2.55938804 |
| 129 | rRNA modification (GO:0000154) | 2.55674440 |
| 130 | DNA deamination (GO:0045006) | 2.55027507 |
| 131 | formation of translation preinitiation complex (GO:0001731) | 2.54765192 |
| 132 | regulation of centrosome cycle (GO:0046605) | 2.54554177 |
| 133 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.53836820 |
| 134 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.53490298 |
| 135 | regulation of T cell tolerance induction (GO:0002664) | 2.53049704 |
| 136 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.52259431 |
| 137 | regulation of histone H3-K9 methylation (GO:0051570) | 2.52211489 |
| 138 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.51964469 |
| 139 | mRNA stabilization (GO:0048255) | 2.51693367 |
| 140 | RNA stabilization (GO:0043489) | 2.51693367 |
| 141 | regulation of sister chromatid cohesion (GO:0007063) | 2.50395234 |
| 142 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.50231984 |
| 143 | negative regulation of RNA splicing (GO:0033119) | 2.50162748 |
| 144 | DNA replication-independent nucleosome organization (GO:0034724) | 2.49686283 |
| 145 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.49686283 |
| 146 | ubiquinone biosynthetic process (GO:0006744) | 2.49392021 |
| 147 | sister chromatid cohesion (GO:0007062) | 2.49240489 |
| 148 | histamine secretion (GO:0001821) | 2.48308175 |
| 149 | regulation of DNA damage checkpoint (GO:2000001) | 2.47998069 |
| 150 | establishment of viral latency (GO:0019043) | 2.47786033 |
| 151 | eosinophil migration (GO:0072677) | 2.47448596 |
| 152 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.46841146 |
| 153 | CENP-A containing nucleosome assembly (GO:0034080) | 2.45742763 |
| 154 | nuclear envelope disassembly (GO:0051081) | 2.45683393 |
| 155 | membrane disassembly (GO:0030397) | 2.45683393 |
| 156 | regulation of cell cycle checkpoint (GO:1901976) | 2.45478533 |
| 157 | protein localization to kinetochore (GO:0034501) | 2.45272404 |
| 158 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.45270137 |
| 159 | cell projection assembly (GO:0030031) | 2.45006843 |
| 160 | positive regulation of chromosome segregation (GO:0051984) | 2.42843264 |
| 161 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.42803706 |
| 162 | regulation of germinal center formation (GO:0002634) | 2.41784811 |
| 163 | aldehyde catabolic process (GO:0046185) | 2.41079484 |
| 164 | histone exchange (GO:0043486) | 2.40366715 |
| 165 | negative regulation of chromatin modification (GO:1903309) | 2.39323112 |
| 166 | kinetochore organization (GO:0051383) | 2.39177095 |
| 167 | cellular response to interferon-alpha (GO:0035457) | 2.39058879 |
| 168 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.38114161 |
| 169 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.37170411 |
| 170 | regulation of mitochondrial translation (GO:0070129) | 2.36258031 |
| 171 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.36191873 |
| 172 | protein-cofactor linkage (GO:0018065) | 2.34812120 |
| 173 | tRNA aminoacylation for protein translation (GO:0006418) | 2.34657318 |
| 174 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.32802174 |
| 175 | mismatch repair (GO:0006298) | 2.32459605 |
| 176 | corticosteroid receptor signaling pathway (GO:0031958) | 2.32420692 |
| 177 | negative regulation of histone modification (GO:0031057) | 2.32173344 |
| 178 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.31779213 |
| 179 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.29850855 |
| 180 | negative regulation of histone acetylation (GO:0035067) | 2.28500063 |
| 181 | regulation of tolerance induction (GO:0002643) | 2.27424731 |
| 182 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.26263463 |
| 183 | mitotic spindle organization (GO:0007052) | 2.25172819 |
| 184 | protein localization to chromosome, centromeric region (GO:0071459) | 2.24946372 |
| 185 | positive regulation of RNA splicing (GO:0033120) | 2.24163435 |
| 186 | mitotic recombination (GO:0006312) | 2.23187482 |
| 187 | chromosome segregation (GO:0007059) | 2.23166381 |
| 188 | regulation of fibroblast apoptotic process (GO:2000269) | 2.21391782 |
| 189 | spindle assembly checkpoint (GO:0071173) | 2.20932789 |
| 190 | response to peptidoglycan (GO:0032494) | 2.20930952 |
| 191 | postreplication repair (GO:0006301) | 2.20659242 |
| 192 | resolution of meiotic recombination intermediates (GO:0000712) | 2.19178230 |
| 193 | axonemal dynein complex assembly (GO:0070286) | 12.1619314 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.98196588 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.14881531 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.11872717 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.88323807 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.48322488 |
| 6 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.46839933 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.01265132 |
| 8 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.96241748 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.80425949 |
| 10 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.69189622 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.56352293 |
| 12 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.47671207 |
| 13 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.45098878 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.42881275 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.42670122 |
| 16 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.39602370 |
| 17 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.29435459 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.27429032 |
| 19 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.22964010 |
| 20 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.22612009 |
| 21 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.22448377 |
| 22 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.16052177 |
| 23 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.14192371 |
| 24 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.13128206 |
| 25 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.03688883 |
| 26 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 2.03135562 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.00843261 |
| 28 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.99093995 |
| 29 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.97563477 |
| 30 | MYC_22102868_ChIP-Seq_BL_Human | 1.95696788 |
| 31 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.89644946 |
| 32 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.87709110 |
| 33 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.86790034 |
| 34 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.82989907 |
| 35 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.82907886 |
| 36 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.79711337 |
| 37 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.78967946 |
| 38 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.78775006 |
| 39 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.77458261 |
| 40 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.76936481 |
| 41 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.70417628 |
| 42 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.68679839 |
| 43 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.67258023 |
| 44 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.66150525 |
| 45 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.66112306 |
| 46 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.65672311 |
| 47 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.63282444 |
| 48 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.62988015 |
| 49 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.62501336 |
| 50 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.59000066 |
| 51 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.58757937 |
| 52 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.58665836 |
| 53 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.58277451 |
| 54 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.58061477 |
| 55 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.54314620 |
| 56 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.54058106 |
| 57 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.51117125 |
| 58 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.50869760 |
| 59 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.49017800 |
| 60 | MYB_26560356_Chip-Seq_TH2_Human | 1.48388769 |
| 61 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.48169096 |
| 62 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.47479690 |
| 63 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.46698092 |
| 64 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.45621633 |
| 65 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.44874297 |
| 66 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44599057 |
| 67 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.44424604 |
| 68 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.43471693 |
| 69 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40781805 |
| 70 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.38953014 |
| 71 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.38514279 |
| 72 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36646611 |
| 73 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.30529918 |
| 74 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.30208684 |
| 75 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.30174602 |
| 76 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29942995 |
| 77 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.28710099 |
| 78 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.26154118 |
| 79 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.25601657 |
| 80 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.25223276 |
| 81 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.24628432 |
| 82 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.21163084 |
| 83 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.20951607 |
| 84 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.20437109 |
| 85 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.19476533 |
| 86 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.19351650 |
| 87 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.18384398 |
| 88 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.16862443 |
| 89 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.15742406 |
| 90 | VDR_22108803_ChIP-Seq_LS180_Human | 1.14846651 |
| 91 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14485668 |
| 92 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.14432901 |
| 93 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.13108741 |
| 94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11374931 |
| 95 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.10621393 |
| 96 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.08999197 |
| 97 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.08696581 |
| 98 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.08388591 |
| 99 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.07816505 |
| 100 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.05646263 |
| 101 | EWS_26573619_Chip-Seq_HEK293_Human | 1.05259244 |
| 102 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.03260207 |
| 103 | MYB_26560356_Chip-Seq_TH1_Human | 1.02786954 |
| 104 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02514204 |
| 105 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99976575 |
| 106 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.98972353 |
| 107 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.98709209 |
| 108 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94508621 |
| 109 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.94174647 |
| 110 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.93848392 |
| 111 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.93021585 |
| 112 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.92363364 |
| 113 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.91728569 |
| 114 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91351281 |
| 115 | UTX_26944678_Chip-Seq_JUKART_Human | 0.89737103 |
| 116 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.88040558 |
| 117 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.86839764 |
| 118 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.85836756 |
| 119 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.83952073 |
| 120 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.83148442 |
| 121 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.82748748 |
| 122 | MAF_26560356_Chip-Seq_TH2_Human | 0.82631404 |
| 123 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.81814291 |
| 124 | P300_27268052_Chip-Seq_Bcells_Human | 0.80977594 |
| 125 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.80972712 |
| 126 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.80358896 |
| 127 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78875084 |
| 128 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.78531748 |
| 129 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.78481105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002132_abnormal_respiratory_system | 4.39208345 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 4.37328278 |
| 3 | MP0000569_abnormal_digit_pigmentation | 4.21751750 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 3.77887809 |
| 5 | MP0003122_maternal_imprinting | 3.10922602 |
| 6 | MP0008057_abnormal_DNA_replication | 2.91376473 |
| 7 | MP0010094_abnormal_chromosome_stability | 2.90379807 |
| 8 | MP0003077_abnormal_cell_cycle | 2.82905179 |
| 9 | MP0003693_abnormal_embryo_hatching | 2.81572879 |
| 10 | MP0003121_genomic_imprinting | 2.81430032 |
| 11 | MP0008877_abnormal_DNA_methylation | 2.79523331 |
| 12 | MP0006036_abnormal_mitochondrial_physio | 2.69930334 |
| 13 | MP0003787_abnormal_imprinting | 2.64383758 |
| 14 | MP0003656_abnormal_erythrocyte_physiolo | 2.59853972 |
| 15 | MP0002277_abnormal_respiratory_mucosa | 2.56901115 |
| 16 | MP0002396_abnormal_hematopoietic_system | 2.51423627 |
| 17 | MP0001835_abnormal_antigen_presentation | 2.50139613 |
| 18 | MP0003786_premature_aging | 2.36034208 |
| 19 | MP0008007_abnormal_cellular_replicative | 2.20328202 |
| 20 | MP0001984_abnormal_olfaction | 2.16698242 |
| 21 | MP0008058_abnormal_DNA_repair | 2.15602861 |
| 22 | MP0008789_abnormal_olfactory_epithelium | 2.15258350 |
| 23 | MP0003183_abnormal_peptide_metabolism | 2.15104474 |
| 24 | MP0004147_increased_porphyrin_level | 2.06848898 |
| 25 | MP0004957_abnormal_blastocyst_morpholog | 2.04780620 |
| 26 | MP0003111_abnormal_nucleus_morphology | 1.95916945 |
| 27 | MP0002160_abnormal_reproductive_system | 1.90931901 |
| 28 | MP0008995_early_reproductive_senescence | 1.90554521 |
| 29 | MP0006035_abnormal_mitochondrial_morpho | 1.85027435 |
| 30 | MP0005076_abnormal_cell_differentiation | 1.72238004 |
| 31 | MP0004808_abnormal_hematopoietic_stem | 1.68624687 |
| 32 | MP0004043_abnormal_pH_regulation | 1.67334451 |
| 33 | MP0003436_decreased_susceptibility_to | 1.64033109 |
| 34 | MP0005671_abnormal_response_to | 1.62416991 |
| 35 | MP0006054_spinal_hemorrhage | 1.59148866 |
| 36 | MP0005000_abnormal_immune_tolerance | 1.58987987 |
| 37 | MP0001800_abnormal_humoral_immune | 1.57340708 |
| 38 | MP0005083_abnormal_biliary_tract | 1.57298780 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.56119546 |
| 40 | MP0002452_abnormal_antigen_presenting | 1.54855287 |
| 41 | MP0003123_paternal_imprinting | 1.53616835 |
| 42 | MP0001730_embryonic_growth_arrest | 1.52125879 |
| 43 | MP0003866_abnormal_defecation | 1.50973676 |
| 44 | MP0003718_maternal_effect | 1.50050187 |
| 45 | MP0002398_abnormal_bone_marrow | 1.49288343 |
| 46 | MP0005394_taste/olfaction_phenotype | 1.46117445 |
| 47 | MP0005499_abnormal_olfactory_system | 1.46117445 |
| 48 | MP0010030_abnormal_orbit_morphology | 1.42018966 |
| 49 | MP0000350_abnormal_cell_proliferation | 1.41949283 |
| 50 | MP0000358_abnormal_cell_content/ | 1.36135447 |
| 51 | MP0002419_abnormal_innate_immunity | 1.35237366 |
| 52 | MP0005025_abnormal_response_to | 1.34324056 |
| 53 | MP0002420_abnormal_adaptive_immunity | 1.34298435 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.33852833 |
| 55 | MP0001819_abnormal_immune_cell | 1.33367106 |
| 56 | MP0002723_abnormal_immune_serum | 1.33027681 |
| 57 | MP0001853_heart_inflammation | 1.29811164 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 1.29461858 |
| 59 | MP0006082_CNS_inflammation | 1.27575575 |
| 60 | MP0005389_reproductive_system_phenotype | 1.25992860 |
| 61 | MP0003698_abnormal_male_reproductive | 1.25973229 |
| 62 | MP0003890_abnormal_embryonic-extraembry | 1.25620096 |
| 63 | MP0009785_altered_susceptibility_to | 1.23562993 |
| 64 | MP0005408_hypopigmentation | 1.22075150 |
| 65 | MP0005058_abnormal_lysosome_morphology | 1.21522265 |
| 66 | MP0005387_immune_system_phenotype | 1.20008335 |
| 67 | MP0001790_abnormal_immune_system | 1.20008335 |
| 68 | MP0002405_respiratory_system_inflammati | 1.18040645 |
| 69 | MP0008932_abnormal_embryonic_tissue | 1.18034233 |
| 70 | MP0000716_abnormal_immune_system | 1.17186987 |
| 71 | MP0001346_abnormal_lacrimal_gland | 1.16663033 |
| 72 | MP0010307_abnormal_tumor_latency | 1.16198820 |
| 73 | MP0009333_abnormal_splenocyte_physiolog | 1.15603426 |
| 74 | MP0010155_abnormal_intestine_physiology | 1.15313017 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 1.13371308 |
| 76 | MP0000703_abnormal_thymus_morphology | 1.13162040 |
| 77 | MP0002102_abnormal_ear_morphology | 1.11552579 |
| 78 | MP0000689_abnormal_spleen_morphology | 1.10751202 |
| 79 | MP0001727_abnormal_embryo_implantation | 1.10679532 |
| 80 | MP0000313_abnormal_cell_death | 1.10418013 |
| 81 | MP0002429_abnormal_blood_cell | 1.09758049 |
| 82 | MP0002006_tumorigenesis | 1.09706604 |
| 83 | MP0000733_abnormal_muscle_development | 1.09531251 |
| 84 | MP0001697_abnormal_embryo_size | 1.08748501 |
| 85 | MP0002234_abnormal_pharynx_morphology | 1.04089693 |
| 86 | MP0005248_abnormal_Harderian_gland | 1.03114694 |
| 87 | MP0003984_embryonic_growth_retardation | 1.03007322 |
| 88 | MP0002084_abnormal_developmental_patter | 1.01764250 |
| 89 | MP0002088_abnormal_embryonic_growth/wei | 1.00358878 |
| 90 | MP0002722_abnormal_immune_system | 0.99199449 |
| 91 | MP0001533_abnormal_skeleton_physiology | 0.98989287 |
| 92 | MP0005397_hematopoietic_system_phenotyp | 0.96198200 |
| 93 | MP0001545_abnormal_hematopoietic_system | 0.96198200 |
| 94 | MP0010352_gastrointestinal_tract_polyps | 0.96129418 |
| 95 | MP0000490_abnormal_crypts_of | 0.95785109 |
| 96 | MP0001145_abnormal_male_reproductive | 0.95644254 |
| 97 | MP0000685_abnormal_immune_system | 0.94476539 |
| 98 | MP0001672_abnormal_embryogenesis/_devel | 0.94060332 |
| 99 | MP0005380_embryogenesis_phenotype | 0.94060332 |
| 100 | MP0003303_peritoneal_inflammation | 0.93083101 |
| 101 | MP0004133_heterotaxia | 0.92980148 |
| 102 | MP0000678_abnormal_parathyroid_gland | 0.92387967 |
| 103 | MP0003448_altered_tumor_morphology | 0.91716392 |
| 104 | MP0003763_abnormal_thymus_physiology | 0.90122865 |
| 105 | MP0001293_anophthalmia | 0.89873778 |
| 106 | MP0005174_abnormal_tail_pigmentation | 0.88728503 |
| 107 | MP0001915_intracranial_hemorrhage | 0.88416060 |
| 108 | MP0002019_abnormal_tumor_incidence | 0.87922676 |
| 109 | MP0002085_abnormal_embryonic_tissue | 0.87460883 |
| 110 | MP0002080_prenatal_lethality | 0.87236225 |
| 111 | MP0000015_abnormal_ear_pigmentation | 0.87087544 |
| 112 | MP0002653_abnormal_ependyma_morphology | 0.87066415 |
| 113 | MP0000427_abnormal_hair_cycle | 0.86194605 |
| 114 | MP0005253_abnormal_eye_physiology | 0.86022860 |
| 115 | MP0004197_abnormal_fetal_growth/weight/ | 0.85542465 |
| 116 | MP0000653_abnormal_sex_gland | 0.83604067 |
| 117 | MP0002166_altered_tumor_susceptibility | 0.81550567 |
| 118 | MP0009697_abnormal_copulation | 0.80719770 |
| 119 | MP0001845_abnormal_inflammatory_respons | 0.80280913 |
| 120 | MP0004381_abnormal_hair_follicle | 0.80278938 |
| 121 | MP0005310_abnormal_salivary_gland | 0.79313536 |
| 122 | MP0002210_abnormal_sex_determination | 0.79308763 |
| 123 | MP0001765_abnormal_ion_homeostasis | 0.78545210 |
| 124 | MP0003221_abnormal_cardiomyocyte_apopto | 0.77825304 |
| 125 | MP0004510_myositis | 0.77263161 |
| 126 | MP0005464_abnormal_platelet_physiology | 0.76764481 |
| 127 | MP0005384_cellular_phenotype | 0.75576680 |
| 128 | MP0005395_other_phenotype | 0.74575895 |
| 129 | MP0008873_increased_physiological_sensi | 0.73175577 |
| 130 | MP0002638_abnormal_pupillary_reflex | 0.73124917 |
| 131 | MP0000383_abnormal_hair_follicle | 0.72080331 |
| 132 | MP0002095_abnormal_skin_pigmentation | 0.71897527 |
| 133 | MP0000428_abnormal_craniofacial_morphol | 0.71581579 |
| 134 | MP0004264_abnormal_extraembryonic_tissu | 0.70913733 |
| 135 | MP0002909_abnormal_adrenal_gland | 0.70478614 |
| 136 | MP0002086_abnormal_extraembryonic_tissu | 0.69542612 |
| 137 | MP0002282_abnormal_trachea_morphology | 0.69238459 |
| 138 | MP0001529_abnormal_vocalization | 0.69137784 |
| 139 | MP0005623_abnormal_meninges_morphology | 0.69019582 |
| 140 | MP0005621_abnormal_cell_physiology | 0.68114913 |
| 141 | MP0001764_abnormal_homeostasis | 0.67100818 |
| 142 | MP0006072_abnormal_retinal_apoptosis | 0.66505457 |
| 143 | MP0009763_increased_sensitivity_to | 0.66128886 |
| 144 | MP0002161_abnormal_fertility/fecundity | 0.65842678 |
| 145 | MP0001929_abnormal_gametogenesis | 0.65571373 |
| 146 | MP0002938_white_spotting | 0.64908604 |
| 147 | MP0003186_abnormal_redox_activity | 0.64902600 |
| 148 | MP0005197_abnormal_uvea_morphology | 0.64655549 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal respiratory motile cilium morphology (HP:0005938) | 9.29482849 |
| 2 | Abnormal respiratory epithelium morphology (HP:0012253) | 9.29482849 |
| 3 | Abnormal respiratory motile cilium physiology (HP:0012261) | 9.10761179 |
| 4 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 9.06848763 |
| 5 | Absent/shortened dynein arms (HP:0200106) | 9.06848763 |
| 6 | Abnormal ciliary motility (HP:0012262) | 8.84315132 |
| 7 | Rhinitis (HP:0012384) | 8.36844005 |
| 8 | Chronic bronchitis (HP:0004469) | 6.58275976 |
| 9 | Bronchiectasis (HP:0002110) | 6.36965127 |
| 10 | Nasal polyposis (HP:0100582) | 5.93958412 |
| 11 | Volvulus (HP:0002580) | 5.31688018 |
| 12 | Abnormality of the nasal mucosa (HP:0000433) | 4.77263974 |
| 13 | Chronic sinusitis (HP:0011109) | 3.90937967 |
| 14 | Bronchitis (HP:0012387) | 3.89059301 |
| 15 | Recurrent sinusitis (HP:0011108) | 3.86679340 |
| 16 | Infertility (HP:0000789) | 3.58293868 |
| 17 | Agnosia (HP:0010524) | 3.40645343 |
| 18 | Occipital encephalocele (HP:0002085) | 3.35349676 |
| 19 | Recurrent otitis media (HP:0000403) | 3.29167737 |
| 20 | Chronic otitis media (HP:0000389) | 3.27490657 |
| 21 | Degeneration of anterior horn cells (HP:0002398) | 3.12952453 |
| 22 | Abnormality of the anterior horn cell (HP:0006802) | 3.12952453 |
| 23 | Recurrent abscess formation (HP:0002722) | 3.10781879 |
| 24 | Male infertility (HP:0003251) | 3.08234651 |
| 25 | Papillary thyroid carcinoma (HP:0002895) | 3.02879730 |
| 26 | Increased nuchal translucency (HP:0010880) | 3.01035624 |
| 27 | Deep philtrum (HP:0002002) | 2.96340885 |
| 28 | Optic nerve coloboma (HP:0000588) | 2.69903984 |
| 29 | Tubular atrophy (HP:0000092) | 2.60340925 |
| 30 | Arterial tortuosity (HP:0005116) | 2.56976678 |
| 31 | Pancreatic fibrosis (HP:0100732) | 2.53290495 |
| 32 | Recurrent bacterial skin infections (HP:0005406) | 2.46450787 |
| 33 | Eczematoid dermatitis (HP:0000976) | 2.44530135 |
| 34 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.43235685 |
| 35 | Deviation of the thumb (HP:0009603) | 2.43235137 |
| 36 | Atelectasis (HP:0100750) | 2.38945157 |
| 37 | True hermaphroditism (HP:0010459) | 2.34452745 |
| 38 | Nephronophthisis (HP:0000090) | 2.31392589 |
| 39 | Proximal placement of thumb (HP:0009623) | 2.30964713 |
| 40 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.29487198 |
| 41 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.29487198 |
| 42 | Pancreatic cysts (HP:0001737) | 2.29485726 |
| 43 | Mediastinal lymphadenopathy (HP:0100721) | 2.28244434 |
| 44 | Trigonocephaly (HP:0000243) | 2.28233751 |
| 45 | Postaxial foot polydactyly (HP:0001830) | 2.24763452 |
| 46 | Broad palm (HP:0001169) | 2.24261876 |
| 47 | Optic neuritis (HP:0100653) | 2.23708871 |
| 48 | Retrobulbar optic neuritis (HP:0100654) | 2.23708871 |
| 49 | Disinhibition (HP:0000734) | 2.23643086 |
| 50 | Myositis (HP:0100614) | 2.23592084 |
| 51 | Amaurosis fugax (HP:0100576) | 2.21614612 |
| 52 | Acute necrotizing encephalopathy (HP:0006965) | 2.20292480 |
| 53 | Recurrent viral infections (HP:0004429) | 2.19733707 |
| 54 | Cutis marmorata (HP:0000965) | 2.17925703 |
| 55 | Vascular tortuosity (HP:0004948) | 2.15880258 |
| 56 | Long eyelashes (HP:0000527) | 2.15633206 |
| 57 | Abnormality of the fingertips (HP:0001211) | 2.14872232 |
| 58 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.14193719 |
| 59 | Abnormality of the labia minora (HP:0012880) | 2.13814375 |
| 60 | Medial flaring of the eyebrow (HP:0010747) | 2.13797516 |
| 61 | Mitochondrial inheritance (HP:0001427) | 2.12609302 |
| 62 | Anencephaly (HP:0002323) | 2.11061749 |
| 63 | Tubulointerstitial nephritis (HP:0001970) | 2.07735495 |
| 64 | Oculomotor apraxia (HP:0000657) | 2.05595999 |
| 65 | Failure to thrive in infancy (HP:0001531) | 2.05192978 |
| 66 | Increased cerebral lipofuscin (HP:0011813) | 2.01009145 |
| 67 | Abnormal hair whorl (HP:0010721) | 2.00493325 |
| 68 | Male pseudohermaphroditism (HP:0000037) | 2.00179764 |
| 69 | Narrow palate (HP:0000189) | 1.99699115 |
| 70 | Hepatocellular necrosis (HP:0001404) | 1.99289886 |
| 71 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.97243453 |
| 72 | Short 4th metacarpal (HP:0010044) | 1.97243453 |
| 73 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.96831315 |
| 74 | Increased CSF lactate (HP:0002490) | 1.95252968 |
| 75 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.95159647 |
| 76 | Acute myeloid leukemia (HP:0004808) | 1.93204875 |
| 77 | Hyperactive renin-angiotensin system (HP:0000841) | 1.90805634 |
| 78 | Orchitis (HP:0100796) | 1.90550991 |
| 79 | Long clavicles (HP:0000890) | 1.90025798 |
| 80 | Prominent nose (HP:0000448) | 1.88304083 |
| 81 | Birth length less than 3rd percentile (HP:0003561) | 1.88217265 |
| 82 | Molar tooth sign on MRI (HP:0002419) | 1.87364425 |
| 83 | Abnormality of midbrain morphology (HP:0002418) | 1.87364425 |
| 84 | Sclerocornea (HP:0000647) | 1.87113284 |
| 85 | Thin upper lip vermilion (HP:0000219) | 1.86955624 |
| 86 | Abnormality of the renal medulla (HP:0100957) | 1.86709948 |
| 87 | Absent frontal sinuses (HP:0002688) | 1.86031432 |
| 88 | Abnormality of the intervertebral disk (HP:0005108) | 1.85627157 |
| 89 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.85343698 |
| 90 | Papilledema (HP:0001085) | 1.83730902 |
| 91 | 3-Methylglutaconic aciduria (HP:0003535) | 1.83444052 |
| 92 | Selective tooth agenesis (HP:0001592) | 1.83403013 |
| 93 | Congenital hepatic fibrosis (HP:0002612) | 1.83364443 |
| 94 | Furrowed tongue (HP:0000221) | 1.82845171 |
| 95 | Thyroid carcinoma (HP:0002890) | 1.81944536 |
| 96 | Progressive macrocephaly (HP:0004481) | 1.81898988 |
| 97 | Cystic liver disease (HP:0006706) | 1.81588837 |
| 98 | Upper motor neuron abnormality (HP:0002127) | 1.81238660 |
| 99 | Congenital primary aphakia (HP:0007707) | 1.80415471 |
| 100 | Hepatic necrosis (HP:0002605) | 1.79313921 |
| 101 | Neoplasm of the oral cavity (HP:0100649) | 1.78139905 |
| 102 | Truncal obesity (HP:0001956) | 1.77341788 |
| 103 | Medulloblastoma (HP:0002885) | 1.76996103 |
| 104 | Bicuspid aortic valve (HP:0001647) | 1.76408495 |
| 105 | Cutaneous melanoma (HP:0012056) | 1.75625717 |
| 106 | Hypoplastic labia majora (HP:0000059) | 1.73901888 |
| 107 | Inappropriate behavior (HP:0000719) | 1.73690191 |
| 108 | Basal ganglia calcification (HP:0002135) | 1.73196539 |
| 109 | Severe combined immunodeficiency (HP:0004430) | 1.71854618 |
| 110 | Cellulitis (HP:0100658) | 1.71754185 |
| 111 | Acute encephalopathy (HP:0006846) | 1.71715623 |
| 112 | Urethral obstruction (HP:0000796) | 1.71511789 |
| 113 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.70829444 |
| 114 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.70792718 |
| 115 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.70320779 |
| 116 | Asplenia (HP:0001746) | 1.69236612 |
| 117 | High pitched voice (HP:0001620) | 1.68557681 |
| 118 | Abnormal number of erythroid precursors (HP:0012131) | 1.67145996 |
| 119 | Abnormality of the labia majora (HP:0012881) | 1.66647381 |
| 120 | Abnormality of the renal cortex (HP:0011035) | 1.66578969 |
| 121 | Aseptic necrosis (HP:0010885) | 1.64747084 |
| 122 | Gait imbalance (HP:0002141) | 1.63471274 |
| 123 | Obstructive lung disease (HP:0006536) | 1.63317471 |
| 124 | Chronic obstructive pulmonary disease (HP:0006510) | 1.63317471 |
| 125 | Spinal cord lesions (HP:0100561) | 1.62751258 |
| 126 | Syringomyelia (HP:0003396) | 1.62751258 |
| 127 | Broad thumb (HP:0011304) | 1.62053008 |
| 128 | Obsessive-compulsive behavior (HP:0000722) | 1.62019920 |
| 129 | Myelodysplasia (HP:0002863) | 1.61944315 |
| 130 | Systemic lupus erythematosus (HP:0002725) | 1.61328636 |
| 131 | Increased intramyocellular lipid droplets (HP:0012240) | 1.60924400 |
| 132 | Prostate neoplasm (HP:0100787) | 1.60163729 |
| 133 | Osteomyelitis (HP:0002754) | 1.59612882 |
| 134 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.59522268 |
| 135 | Increased hepatocellular lipid droplets (HP:0006565) | 1.58075165 |
| 136 | Exercise intolerance (HP:0003546) | 1.58024601 |
| 137 | Slender long bone (HP:0003100) | 1.57717278 |
| 138 | Blepharitis (HP:0000498) | 1.57088064 |
| 139 | Ectopic kidney (HP:0000086) | 1.56932570 |
| 140 | IgM deficiency (HP:0002850) | 1.56754660 |
| 141 | Low anterior hairline (HP:0000294) | 1.56582255 |
| 142 | Chronic hepatic failure (HP:0100626) | 1.56310852 |
| 143 | Thick eyebrow (HP:0000574) | 1.56267008 |
| 144 | Growth hormone deficiency (HP:0000824) | 1.55058489 |
| 145 | Sloping forehead (HP:0000340) | 1.53556027 |
| 146 | Patellar aplasia (HP:0006443) | 1.53157175 |
| 147 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.52859837 |
| 148 | Lipid accumulation in hepatocytes (HP:0006561) | 1.52732748 |
| 149 | Recurrent bronchitis (HP:0002837) | 1.52653341 |
| 150 | Pendular nystagmus (HP:0012043) | 1.52286090 |
| 151 | Abnormal biliary tract physiology (HP:0012439) | 1.51823164 |
| 152 | Bile duct proliferation (HP:0001408) | 1.51823164 |
| 153 | Short philtrum (HP:0000322) | 1.50886238 |
| 154 | Increased serum lactate (HP:0002151) | 1.50355408 |
| 155 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.50235247 |
| 156 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.49754076 |
| 157 | Combined immunodeficiency (HP:0005387) | 1.49032702 |
| 158 | Colon cancer (HP:0003003) | 1.48862068 |
| 159 | Cerebral edema (HP:0002181) | 1.47237328 |
| 160 | Aplastic anemia (HP:0001915) | 1.46849245 |
| 161 | Postaxial hand polydactyly (HP:0001162) | 1.45210839 |
| 162 | Nephrogenic diabetes insipidus (HP:0009806) | 1.44664298 |
| 163 | Nephropathy (HP:0000112) | 1.42685672 |
| 164 | Preaxial hand polydactyly (HP:0001177) | 1.42505262 |
| 165 | Increased muscle lipid content (HP:0009058) | 1.41902151 |
| 166 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.41419735 |
| 167 | Spinal muscular atrophy (HP:0007269) | 1.37330774 |
| 168 | Median cleft lip (HP:0000161) | 1.33906289 |
| 169 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.33672876 |
| 170 | Respiratory failure (HP:0002878) | 1.30785043 |
| 171 | Carpal bone hypoplasia (HP:0001498) | 1.30004155 |
| 172 | Lactic acidosis (HP:0003128) | 1.29551324 |
| 173 | Panhypogammaglobulinemia (HP:0003139) | 1.28581758 |
| 174 | Optic disc pallor (HP:0000543) | 1.26997397 |
| 175 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.25898739 |
| 176 | Renal cortical cysts (HP:0000803) | 1.22549930 |
| 177 | Cerebral hypomyelination (HP:0006808) | 1.20532894 |
| 178 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.20472323 |
| 179 | Premature ovarian failure (HP:0008209) | 1.19601664 |
| 180 | Multicystic kidney dysplasia (HP:0000003) | 1.17204918 |
| 181 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.17131221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 4.87500032 |
| 2 | SIK3 | 4.52833159 |
| 3 | CDC7 | 3.77017892 |
| 4 | VRK2 | 3.67451706 |
| 5 | STK16 | 3.05261571 |
| 6 | IRAK4 | 2.74146931 |
| 7 | NEK1 | 2.71270464 |
| 8 | NME1 | 2.45954595 |
| 9 | PBK | 2.39956157 |
| 10 | TSSK6 | 2.38171910 |
| 11 | CDK12 | 2.34529432 |
| 12 | MAP3K10 | 2.33452101 |
| 13 | ACVR1B | 2.27768006 |
| 14 | PASK | 2.25260397 |
| 15 | MAP4K2 | 2.17704424 |
| 16 | ATR | 2.09873922 |
| 17 | ERBB3 | 2.03546366 |
| 18 | TAOK3 | 1.89552571 |
| 19 | TGFBR1 | 1.73726886 |
| 20 | NEK2 | 1.73025615 |
| 21 | PLK3 | 1.71953957 |
| 22 | BUB1 | 1.67454999 |
| 23 | TLK1 | 1.66978829 |
| 24 | TYK2 | 1.55831332 |
| 25 | MAP4K1 | 1.47478695 |
| 26 | BCR | 1.47040385 |
| 27 | MARK3 | 1.46327204 |
| 28 | TBK1 | 1.45125001 |
| 29 | KIT | 1.42815311 |
| 30 | MKNK1 | 1.40852610 |
| 31 | CDK6 | 1.39696032 |
| 32 | RIPK4 | 1.36753966 |
| 33 | MAP3K12 | 1.32015633 |
| 34 | NME2 | 1.31967938 |
| 35 | EPHA2 | 1.31875921 |
| 36 | PNCK | 1.26209096 |
| 37 | MST4 | 1.23816790 |
| 38 | BRD4 | 1.21669165 |
| 39 | EEF2K | 1.19201272 |
| 40 | CHUK | 1.16565139 |
| 41 | PLK4 | 1.16333797 |
| 42 | STK10 | 1.12699194 |
| 43 | RPS6KA4 | 1.11984828 |
| 44 | TXK | 1.09226288 |
| 45 | MAPKAPK3 | 1.08712265 |
| 46 | TEC | 1.08541501 |
| 47 | STK3 | 1.07729048 |
| 48 | CLK1 | 1.07520810 |
| 49 | BTK | 1.06983473 |
| 50 | CHEK1 | 1.06336968 |
| 51 | LRRK2 | 1.05824079 |
| 52 | SMG1 | 1.04817558 |
| 53 | BRSK2 | 1.02452533 |
| 54 | CDK8 | 1.00883899 |
| 55 | CAMK1G | 0.99926862 |
| 56 | PINK1 | 0.99185292 |
| 57 | NUAK1 | 0.99007328 |
| 58 | TESK1 | 0.97967434 |
| 59 | RPS6KB2 | 0.97498115 |
| 60 | ATM | 0.95213870 |
| 61 | CCNB1 | 0.94287946 |
| 62 | SIK2 | 0.90998126 |
| 63 | PLK1 | 0.90542752 |
| 64 | IKBKE | 0.90388322 |
| 65 | MAP3K13 | 0.88130603 |
| 66 | ZAK | 0.87022119 |
| 67 | SRPK1 | 0.86482459 |
| 68 | CSK | 0.86409508 |
| 69 | DYRK3 | 0.86208237 |
| 70 | PRKCI | 0.85248193 |
| 71 | TESK2 | 0.84329786 |
| 72 | AURKA | 0.83711717 |
| 73 | PLK2 | 0.83015517 |
| 74 | AURKB | 0.82428750 |
| 75 | PDK2 | 0.81571123 |
| 76 | PAK4 | 0.80072986 |
| 77 | ZAP70 | 0.79706162 |
| 78 | TTK | 0.79469269 |
| 79 | JAK1 | 0.79267717 |
| 80 | EIF2AK3 | 0.79038658 |
| 81 | CDK19 | 0.78077413 |
| 82 | EIF2AK1 | 0.77599637 |
| 83 | ALK | 0.77149833 |
| 84 | CDK2 | 0.77019378 |
| 85 | PIM1 | 0.76511991 |
| 86 | JAK3 | 0.75624680 |
| 87 | YES1 | 0.75479009 |
| 88 | ITK | 0.74691263 |
| 89 | CSF1R | 0.74377281 |
| 90 | CDK1 | 0.74356412 |
| 91 | IRAK2 | 0.73234411 |
| 92 | BCKDK | 0.72252618 |
| 93 | CAMK1D | 0.70486608 |
| 94 | PIM2 | 0.70269381 |
| 95 | SCYL2 | 0.68041586 |
| 96 | STK24 | 0.65165602 |
| 97 | BRSK1 | 0.64420124 |
| 98 | IRAK3 | 0.64168708 |
| 99 | PRKCQ | 0.64147567 |
| 100 | ERN1 | 0.63403793 |
| 101 | CSNK2A2 | 0.62840775 |
| 102 | EPHA3 | 0.62752510 |
| 103 | RPS6KA5 | 0.62507321 |
| 104 | SYK | 0.62495903 |
| 105 | CDK4 | 0.62434223 |
| 106 | WEE1 | 0.61231486 |
| 107 | VRK1 | 0.60978287 |
| 108 | PTK2B | 0.60949204 |
| 109 | KDR | 0.60722011 |
| 110 | RIPK1 | 0.60695990 |
| 111 | MAPKAPK2 | 0.59916175 |
| 112 | WNK1 | 0.58076838 |
| 113 | MAP2K7 | 0.56486331 |
| 114 | CDK7 | 0.54839201 |
| 115 | TRPM7 | 0.53852796 |
| 116 | CSNK2A1 | 0.52512271 |
| 117 | FGFR1 | 0.51587112 |
| 118 | MAPK14 | 0.50417438 |
| 119 | ILK | 0.50029025 |
| 120 | MAPKAPK5 | 0.49658586 |
| 121 | GRK6 | 0.48854358 |
| 122 | LCK | 0.46514497 |
| 123 | ADRBK2 | 0.46288795 |
| 124 | UHMK1 | 0.45492571 |
| 125 | PRKDC | 0.45463213 |
| 126 | CSNK1E | 0.43520447 |
| 127 | BMPR1B | 0.42722227 |
| 128 | STK4 | 0.42524650 |
| 129 | CHEK2 | 0.42007010 |
| 130 | MAPK8 | 0.41997751 |
| 131 | NEK9 | 0.41125860 |
| 132 | IKBKB | 0.40361209 |
| 133 | PKN2 | 0.40306823 |
| 134 | MAPK9 | 0.39695334 |
| 135 | IRAK1 | 0.38920952 |
| 136 | EGFR | 0.37841703 |
| 137 | AKT1 | 0.37637690 |
| 138 | LYN | 0.37453608 |
| 139 | MAP3K8 | 0.36672866 |
| 140 | PAK1 | 0.34239451 |
| 141 | NLK | 0.30101867 |
| 142 | MST1R | 0.29873149 |
| 143 | RPS6KB1 | 0.25653439 |
| 144 | CAMKK2 | 0.25320671 |
| 145 | CDK9 | 0.25008379 |
| 146 | WNK4 | 0.25002698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Huntingtons disease_Homo sapiens_hsa05016 | 2.98676894 |
| 2 | Spliceosome_Homo sapiens_hsa03040 | 2.71346916 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.66665561 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.37843743 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 2.27292868 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.25320097 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.20832982 |
| 8 | Cell cycle_Homo sapiens_hsa04110 | 2.15391162 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 2.11959730 |
| 10 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.09608333 |
| 11 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.04126506 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.98897508 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.91490949 |
| 14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.88205911 |
| 15 | Base excision repair_Homo sapiens_hsa03410 | 1.83649751 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.79703861 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 1.79227816 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.62026692 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.60594405 |
| 20 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.59697465 |
| 21 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.59611552 |
| 22 | Protein export_Homo sapiens_hsa03060 | 1.59546339 |
| 23 | Homologous recombination_Homo sapiens_hsa03440 | 1.57906413 |
| 24 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55183217 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 1.53829666 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.52115763 |
| 27 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.51404635 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.45723675 |
| 29 | Alzheimers disease_Homo sapiens_hsa05010 | 1.42186498 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.40836517 |
| 31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.39240314 |
| 32 | Basal transcription factors_Homo sapiens_hsa03022 | 1.37097265 |
| 33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.33751761 |
| 34 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.32624258 |
| 35 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.30679061 |
| 36 | RNA degradation_Homo sapiens_hsa03018 | 1.29776993 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.29403685 |
| 38 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.28172719 |
| 39 | Phagosome_Homo sapiens_hsa04145 | 1.27992191 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.27985902 |
| 41 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.27252482 |
| 42 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.27008731 |
| 43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.25057255 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.24210312 |
| 45 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.23293482 |
| 46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.23129837 |
| 47 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.22565866 |
| 48 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.22012877 |
| 49 | Tuberculosis_Homo sapiens_hsa05152 | 1.21901197 |
| 50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.21005230 |
| 51 | Pertussis_Homo sapiens_hsa05133 | 1.18893190 |
| 52 | Purine metabolism_Homo sapiens_hsa00230 | 1.18303746 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.16066075 |
| 54 | Salmonella infection_Homo sapiens_hsa05132 | 1.13894278 |
| 55 | Influenza A_Homo sapiens_hsa05164 | 1.12197767 |
| 56 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.11991201 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.11384134 |
| 58 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.10363735 |
| 59 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.09394942 |
| 60 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.04950720 |
| 61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.04560068 |
| 62 | HTLV-I infection_Homo sapiens_hsa05166 | 1.04285181 |
| 63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.02754827 |
| 64 | Lysosome_Homo sapiens_hsa04142 | 1.02751772 |
| 65 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.01372236 |
| 66 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.00998874 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.00290690 |
| 68 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.96289819 |
| 69 | Colorectal cancer_Homo sapiens_hsa05210 | 0.96020123 |
| 70 | Asthma_Homo sapiens_hsa05310 | 0.93629588 |
| 71 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.92315682 |
| 72 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.91601972 |
| 73 | Shigellosis_Homo sapiens_hsa05131 | 0.91265466 |
| 74 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.90869156 |
| 75 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.89802540 |
| 76 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89692108 |
| 77 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.88985005 |
| 78 | Histidine metabolism_Homo sapiens_hsa00340 | 0.88978710 |
| 79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.87637395 |
| 80 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.87593714 |
| 81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87341571 |
| 82 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.86847360 |
| 83 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.86383193 |
| 84 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.84897006 |
| 85 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.83494438 |
| 86 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.83151372 |
| 87 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.82289369 |
| 88 | RNA polymerase_Homo sapiens_hsa03020 | 0.82045861 |
| 89 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.81428157 |
| 90 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.81085077 |
| 91 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79695972 |
| 92 | Apoptosis_Homo sapiens_hsa04210 | 0.79165614 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.78308231 |
| 94 | Peroxisome_Homo sapiens_hsa04146 | 0.75040900 |
| 95 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.74890861 |
| 96 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73458184 |
| 97 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.69838974 |
| 98 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.69313075 |
| 99 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.68826973 |
| 100 | Malaria_Homo sapiens_hsa05144 | 0.67123006 |
| 101 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.66821241 |
| 102 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65564183 |
| 103 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.65248160 |
| 104 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.63775798 |
| 105 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63551943 |
| 106 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.63181265 |
| 107 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.63112958 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.61902407 |
| 109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60616205 |
| 110 | Olfactory transduction_Homo sapiens_hsa04740 | 0.60278501 |
| 111 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.59770426 |
| 112 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58896136 |
| 113 | Adherens junction_Homo sapiens_hsa04520 | 0.57702019 |
| 114 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.57380783 |
| 115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57060095 |
| 116 | Prostate cancer_Homo sapiens_hsa05215 | 0.56574200 |
| 117 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54489680 |
| 118 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53929075 |
| 119 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53708821 |
| 120 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.53191315 |
| 121 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.52854790 |
| 122 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52495649 |
| 123 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.51465041 |
| 124 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51098234 |
| 125 | Retinol metabolism_Homo sapiens_hsa00830 | 0.51080886 |
| 126 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.49688581 |
| 127 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49320404 |
| 128 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.46101948 |
| 129 | Carbon metabolism_Homo sapiens_hsa01200 | 0.45736643 |
| 130 | Hepatitis C_Homo sapiens_hsa05160 | 0.45634225 |
| 131 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44799428 |
| 132 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.43816054 |
| 133 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43342989 |
| 134 | Pathways in cancer_Homo sapiens_hsa05200 | 0.42539181 |
| 135 | Ribosome_Homo sapiens_hsa03010 | 0.41838806 |
| 136 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41121065 |
| 137 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.37939442 |
| 138 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.37627656 |
| 139 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.36905997 |
| 140 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.34048503 |
| 141 | Phototransduction_Homo sapiens_hsa04744 | 0.33389499 |
| 142 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32269873 |
| 143 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29077978 |
| 144 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.26713051 |
| 145 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.20493007 |
| 146 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.18040253 |
| 147 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.15874152 |
| 148 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15472215 |

